Total Payments
$2,075
2024 Payments
$96.07
Companies
21
Transactions
94
Medicare Patients
5,302
Medicare Billing
$784,053
Payment Breakdown by Category
Food & Beverage$2,075 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,075 | 94 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $991.24 | 50 | $0 (2024) |
| Janssen Biotech, Inc. | $166.74 | 5 | $0 (2023) |
| Celgene Corporation | $126.25 | 7 | $0 (2024) |
| AcelRx Pharmaceuticals, Inc. | $116.56 | 2 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $105.30 | 2 | $0 (2020) |
| Boston Scientific Corporation | $96.97 | 2 | $0 (2022) |
| Allergan Inc. | $89.65 | 6 | $0 (2019) |
| Mallinckrodt LLC | $71.00 | 1 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $51.27 | 3 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $45.77 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $96.07 | 5 | ABBVIE INC. ($73.21) |
| 2023 | $273.59 | 10 | Janssen Biotech, Inc. ($113.33) |
| 2022 | $291.63 | 17 | ABBVIE INC. ($172.14) |
| 2021 | $393.36 | 17 | AbbVie Inc. ($162.03) |
| 2020 | $103.76 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($89.07) |
| 2019 | $54.22 | 4 | AbbVie, Inc. ($43.33) |
| 2018 | $395.52 | 22 | AbbVie, Inc. ($254.55) |
| 2017 | $466.77 | 17 | AbbVie, Inc. ($189.10) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: IMMUNOLOGY | ||||||
| 04/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: IMMUNOLOGY | ||||||
| 02/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/11/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.86 | General |
| Category: Neuroscience | ||||||
| 11/15/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $113.33 | General |
| Category: Immunology | ||||||
| 08/24/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.59 | General |
| Category: Neuroscience | ||||||
| 06/23/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/25/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: IMMUNOLOGY | ||||||
| 05/05/2023 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $24.13 | General |
| 04/10/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/07/2023 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Gastrointestinal AI | ||||||
| 03/27/2023 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $22.26 | General |
| 02/23/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.81 | General |
| Category: Neuroscience | ||||||
| 08/02/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/20/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: Neuroscience | ||||||
| 07/11/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/22/2022 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/06/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,291 | 1,485 | $463,232 | $186,931 |
| 2022 | 19 | 1,230 | 1,455 | $453,960 | $181,600 |
| 2021 | 17 | 1,362 | 1,621 | $501,031 | $207,600 |
| 2020 | 19 | 1,419 | 1,676 | $501,011 | $207,923 |
Total Patients
5,302
Total Services
6,237
Medicare Billing
$784,053
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 188 | 189 | $87,885 | $39,116 | 44.5% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 49 | 152 | $79,800 | $32,717 | 41.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 230 | 288 | $32,256 | $19,566 | 60.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 94 | 95 | $28,143 | $17,410 | 61.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 178 | $29,192 | $16,771 | 57.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 133 | 133 | $59,850 | $15,406 | 25.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 110 | 110 | $46,750 | $8,851 | 18.9% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 69 | 71 | $25,287 | $8,696 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $16,683 | $8,502 | 51.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 43 | 43 | $19,350 | $6,155 | 31.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 52 | 53 | $18,500 | $4,475 | 24.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $6,232 | $3,311 | 53.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 14 | $4,158 | $2,586 | 62.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $3,405 | $1,521 | 44.7% |
| 45331 | Biopsy of lower large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $2,593 | $1,040 | 40.1% |
| 45330 | Diagnostic exam of lower portion of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $3,150 | $805.83 | 25.6% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 49 | 168 | $88,200 | $36,916 | 41.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 139 | 141 | $65,565 | $28,605 | 43.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 88 | 88 | $26,069 | $16,208 | 62.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 163 | $26,732 | $15,337 | 57.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 107 | 108 | $29,029 | $14,073 | 48.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 115 | 115 | $51,750 | $13,675 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 155 | 202 | $22,624 | $13,340 | 59.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 152 | 153 | $61,475 | $11,824 | 19.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 64 | 64 | $28,800 | $9,220 | 32.0% |
About Dr. Thomas Mathew, M.D
Dr. Thomas Mathew, M.D is a Internal Medicine healthcare provider based in Summerfield, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841339090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Mathew, M.D has received a total of $2,075 in payments from pharmaceutical and medical device companies, with $96.07 received in 2024. These payments were reported across 94 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,075).
As a Medicare-enrolled provider, Mathew has provided services to 5,302 Medicare beneficiaries, totaling 6,237 services with total Medicare billing of $784,053. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Summerfield, FL
- Active Since 02/05/2007
- Last Updated 07/07/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1841339090
Products in Payments
- LINZESS (Drug) $170.82
- Humira (Biological) $136.70
- DSUVIA (Drug) $116.56
- STELARA (Biological) $113.33
- HUMIRA (Biological) $108.36
- ZEPOSIA (Drug) $103.99
- Viekira (Drug) $102.35
- RINVOQ (Biological) $96.94
- Mavyret (Drug) $96.40
- ENTYVIO (Biological) $89.07
- GENERAL - THERAPIES (Device) $83.46
- OFIRMEV (Drug) $71.00
- SKYRIZI (Biological) $59.32
- BYSTOLIC (Drug) $55.62
- REMICADE (Biological) $53.41
- MAVYRET (Drug) $52.27
- RELISTOR (Drug) $50.65
- XELJANZ (Drug) $43.44
- Creon (Drug) $33.65
- MOVIPREP (Drug) $32.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Summerfield
Dr. Marivic Villa, M.d, M.D
Internal Medicine — Payments: $6,986
Internal Medicine $6,986
Gloria Hernandez, Md, MD
Internal Medicine — Payments: $5,723
Internal Medicine $5,723
Luna Beck, M.d, M.D
Internal Medicine — Payments: $2,672
Internal Medicine $2,672
Dr. Ma Aung, M.d, M.D
Internal Medicine — Payments: $2,316
Internal Medicine $2,316
Mrs. Sara Gitte, Md, MD
Internal Medicine — Payments: $2,272
Internal Medicine $2,272
Dr. Page Smith, M.d, M.D
Internal Medicine — Payments: $2,256
Internal Medicine $2,256